George Clinical welcomes Cardio Union and The George Institute for Global Health’s establishment of the Heart Health Research Center

BEIJING – October 15, 2016 – George Clinical welcomes the establishment of the Heart Health Research Center, a collaborative initiative developed by Cardio Union, an emerging multi-disciplinary healthcare organisation and George Clinical’s parent organisation, The George Institute for Global Health.  The Heart Health Research Center (HHRC) will help to address the growing burden of cardiovascular […]

Read More

Intensive blood pressure lowering reduces heart attacks

One quarter of the world’s adult population suffers from hypertension, and although it has no obvious symptoms, it can lead to heart attacks, stroke, kidney failure and blindness. Despite this, there has been great uncertainty as to how intensively blood pressure should be lowered to obtain maximal benefit and minimize risks. Researchers from Australia, China, […]

Read More

Benefits of DPPIV-inhibitors still uncertain

The recent SAVOR-TIMI 53 (saxagliptin) and EXAMINE (alogliptin) trials recently reported the effects of the DPPIV inhibitor class of glucose lowering agents in people with diabetes. As required by the US FDA, both drugs were found not to increase cardiovascular risk, allowing the agents to be registered for use in that country. Good news, it would […]

Read More

Too busy for a healthy lifestyle?

As active contributors in research, sometimes it’s nice to take a step back and reflect how our work evolves from novel treatment to everyday practice. So much of how we choose to live our life now was determined by past evidence. But with the volume of information out there, it’s difficult to sift out the […]

Read More

Twitter Facebook LinkedIn